[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336686-105":59,"doc-detail-336686-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","large-language-model-produces-high-accurate-diagnosis-of-cancer-from-end-motif-profiles-of-cell-free-dna-abstract","Large language model produces high accurate diagnosis of cancer from end-motif profiles of cell-free DNA - Abstract","","Instruction-tuned large language models enable alignment with human intent, and an instruction-tuned LLM-based system (iLLMAC) is presented for cancer assessment. The method detects cancer from cell-free DNA (cfDNA) end-motif profiles using plasma cfDNA sequencing data from 1135 cancer patients and 1106 controls across three datasets. iLLMAC achieves AUROC values of 0.866 for cancer diagnosis and 0.924 for hepatocellular carcinoma (HCC) detection with 16 end-motifs, improving with more motifs and reaching 0.912 and 0.938 on an external test set at 64 end-motifs.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/large-language-model-produces-high-accurate-diagnosis-of-cancer-from-end-motif-profiles-of-cell-free-dna-abstract/336686/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/large-language-model-produces-high-accurate-diagnosis-of-cancer-from-end-motif-profiles-of-cell-free-dna-abstract/336686.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What task does iLLMAC perform in cfDNA-based cancer assessment?","Question",{"text":112,"@type":113},"iLLMAC detects cancer using cfDNA end-motif profiles derived from plasma cfDNA sequencing data.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was iLLMAC developed and evaluated?",{"text":117,"@type":113},"It was trained on data from 1135 cancer patients and 1106 controls across three datasets and then tested externally using additional cohorts.",{"name":119,"@type":110,"acceptedAnswer":120},"How does performance change as the number of end-motifs increases?",{"text":121,"@type":113},"Diagnostic performance improves with more motifs, reaching higher AUROC values, and at 64 end-motifs the external test set shows AUROC values of 0.912 for cancer diagnosis and 0.938 for HCC detection.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336686,1790168985,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Briefings in Bioinformatics, 2024, 25(5), bbae430  \n[https://doi.org/10.1093/bib/bbae430](https://doi.org/10.1093/bib/bbae430)  \nProblem Solving Protocol  \nLarge language model produces high accurate diagnosis of cancer from end-motif profiles of cell-free DNA  \nJilei Liu1 ,‡, Hongru Shen1 ,‡, Kexin Chen2 , *, Xiangchun Li 1 , *  \n1 Key Laboratory of Cancer Prevention and Therapy, Tianjin Cancer Institute, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Medical University, Tianjin, 300060, China  \n2 Department of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology of Tianjin, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Medical University, Tianjin, 300060, China  \n*Corresponding author. Xiangchun Li, Tianjin Cancer Institute, Tianjin Medical University Cancer Institute and Hospital, Huanhu Xi Road, Tiyuan Bei, Hexi District, Tianjin, 300060, China. E-mail: [lixiangchun@tmu.edu.cn and Kexin Chen](lixiangchun@tmu.edu.cn and Kexin Chen), Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer  \nInstitute and Hospital, Huanhu Xi Road, Tiyuan Bei, Hexi District, Tianjin, 300060, China. E-mail: [chenkexin@tmu.edu.cn](chenkexin@tmu.edu.cn)  \n‡Jilei Liu and Hongru Shen contributed equally to this work.  \nAbstract  \nInstruction-tuned large language models (LLMs) demonstrate exceptional ability to align with human intentions. We present an LLMbased model—instruction-tuned LLM for assessment of cancer (iLLMAC)—that can detect cancer using cell-free deoxyribonucleic acid (cfDNA) end-motif profiles. Developed on plasma cfDNA sequencing data from 1135 cancer patients and 1106 controls across three datasets, iLLMAC achieved area under the receiver operating curve (AUROC) of 0.866 [95% confidence interval (CI), 0.773–0.959] for cancer diagnosis and 0.924 (95% CI, 0.841–1.0) for hepatocellular carcinoma (HCC) detection using 16 end-motifs. Performance increased with more motifs, reaching 0.886 (95% CI, 0.794–0.977) and 0.956 (95% CI, 0.89–1.0) for cancer diagnosis and HCC detection, respectively, with 64 end-motifs. On an external-testing set, iLLMAC achieved AUROC of 0.912 (95% CI, 0.849–0.976) for cancer diagnosis and 0.938 (95% CI, 0.885–0.992) for HCC detection with 64 end-motifs, significantly outperforming benchmarked methods. Furthermore, iLLMAC achieved high classification performance on datasets with bisulfite and 5-hydroxymethylcytosine sequencing. Our study highlights the effectiveness of LLM-based instruction-tuning for cfDNA-based cancer detection.  \nKeywords: cell-free DNA; early cancer diagnosis; large language models  \nIntroduction  \nThe advent of large language models (LLMs) has revolutionized natural language understanding [1 , 2] . LLMs such as Generative Pre-Training 3 (GPT-3), Large Language Model Meta AI (LLaMA), and Pathways Language Model (PALM) are continuously setting new benchmarks in this field [3–5] . These foundation models, trained on extensive and diverse datasets, can be fine-tuned for various downstream applications to achieve state-of-the-art performance in natural language understanding task [6–9] . However, LLMs often misinterpret instructions and exhibit biases in their generated contents [10] . To address these issues, instructionbased tuning has been developed to better align LLMs with human instructions and expectations [11] . This involves curating human demonstrations to fine-tune LLMs, improving their adherence to human instructions and extending their capabilities to tasks such as classification, summarization, and question-answering [12–14] . Despite these advancements, the application of instruction-tuned LLMs in cell-free deoxyribonucleic acid (cfDNA)-based cancer diagnosis ha","cbCaic7NKoaQSRwx","https://ap.wps.com/l/cbCaic7NKoaQSRwx","pdf",985786,"English","# Abstract\n## Model iLLMAC and dataset design\n## Diagnostic performance and motif count\n## External testing and benchmarking\n## Compatibility with other sequencing modalities\n# Introduction\n## Instruction-tuned LLM background\n## cfDNA fragmentation and end-motifs for diagnosis","[{\"question\":\"What task does iLLMAC perform in cfDNA-based cancer assessment?\",\"answer\":\"iLLMAC detects cancer using cfDNA end-motif profiles derived from plasma cfDNA sequencing data.\"},{\"question\":\"How was iLLMAC developed and evaluated?\",\"answer\":\"It was trained on data from 1135 cancer patients and 1106 controls across three datasets and then tested externally using additional cohorts.\"},{\"question\":\"How does performance change as the number of end-motifs increases?\",\"answer\":\"Diagnostic performance improves with more motifs, reaching higher AUROC values, and at 64 end-motifs the external test set shows AUROC values of 0.912 for cancer diagnosis and 0.938 for HCC detection.\"}]","Large language model produces high accurate diagnosis of cancer from end-motif profiles of cell-free DNA - Abstract | PDF",1790016159,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10d88923354b90589f93e1bbf35b145a.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24ea9607c0a1105da1c03217f1bc5cb8.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5d3cc14aab397c71be21a0589d287ad.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19730be1fa4e4af4657dcff530d673cd.webp",980,1287]